Silberstein David S.
SEC insider (Form 3/4/5 filer). CIK 0001812659. Director at Lantern Pharma Inc. (LTRN). 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 9, 2026. Located in DALLAS, TX.
Companies Silberstein David S. has filed insider reports for
- Lantern Pharma Inc. (LTRN): Director
Silberstein David S.
CIK: 0001812659
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lantern Pharma Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jan 9, 2026LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
25K shares- - Jan 9, 2026LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
17.3K shares- - Nov 4, 2021LTRN
Lantern Pharma Inc.
DispositionDirectStock Option (Right to Buy)
3.2K shares- - Nov 4, 2021LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
3.2K shares- - Jun 15, 2020LTRN
Lantern Pharma Inc.
DispositionDirectStock Option (Right to Buy)
9.1K shares- - Jun 15, 2020LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
9.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 9, 2026 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Jan 9, 2026 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 17,307 | - | - | Direct |
| Nov 4, 2021 | LTRN Lantern Pharma Inc. | Disposition Stock Option (Right to Buy) | 3,200 | - | - | Direct |
| Nov 4, 2021 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 3,200 | - | - | Direct |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | Disposition Stock Option (Right to Buy) | 9,135 | - | - | Direct |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 9,135 | - | - | Direct |
1-6 of 6 transactions